Morbidly Adherent Placenta Program
Specialized, experienced care for placenta accreta, increta and percreta
Our Morbidly Adherent Placenta (MAP) program offers women a proven resource for the management of these rare, potentially life-threatening pregnancies.
With risks that include potentially massive blood loss in the mother and premature birth, women with morbidly adherent placenta require specialized care from an experienced team – one that is well equipped to respond to complex challenges during pregnancy and delivery.
A Rare Level of Expertise
MAP pregnancies occur when the placenta grows too deeply into the wall of the uterus and is unable to detach at childbirth. The condition is also known as placenta accreta, placenta increta or placenta percreta, depending on the depth of the attachment.
Our maternal-fetal medicine physicians, specialists in the treatment of high-risk pregnancies, offer a rare level of expertise.
In 2016, we treated 35 women with morbidly adherent placenta, a condition many OB/GYNs rarely encounter. With our proven experience and outcomes, we are a trusted resource to which one can turn, even for the most challenging cases.
Proven Protocols and Outcomes
The serious risks posed by these pregnancies require protocols to be in place to immediately address emergencies when they arise.
We are prepared and equipped 24/7 to address the needs of mother and baby, coordinating and mobilizing lifesaving resources that improve outcomes.
You and your baby benefit from:
- A multidisciplinary medical and surgical team experienced in managing MAP pregnancies and deliveries, setting our program apart. Our MAP health care team includes specialists from Maternal-Fetal Medicine, Anesthesiology, Transfusion Medicine, Urology, Pulmonary Medicine, Critical Care, Neonatology, Interventional Radiology, Pathology, Respiratory Therapy and Psychiatry, in addition to support groups, specialized nurses and support staff.
- Blood bank and transfusion medicine services with the blood products and expertise required to address serious bleeding problems
- Immediate access to Texas Children’s Neonatal Intensive Care Unit for lifesaving interventions, should your baby need it
- Delivery at a state-of-the-art center specializing in high-risk pregnancies, a proven success factor in MAP deliveries
- Development of strategies to reduce blood loss whenever possible, with a focus on continual quality improvement
Morbidly adherent placenta typically causes few to no early symptoms. The sooner your condition is diagnosed, the sooner plans can be put in place to minimize the risk of uncontrolled bleeding at delivery.
We offer women early detection using the latest advancements in maternal and fetal imaging, including state-of-the-art 2D and 3D ultrasound systems, and MRI for selected cases.
Our imaging team has extensive experience identifying at-risk patients and evaluating and treating morbidly adherent placenta.
A Carefully Planned Delivery
Your delivery is carefully planned and timed to minimize the risk of hemorrhage and the impact of premature birth on your baby.
While treatment is determined on a case-by-case basis, our patients are typically delivered 4 to 5 weeks ahead of their due date. In general, the safest approach is a planned cesarean delivery followed immediately by a hysterectomy. This proven method leaves the placenta untouched, reducing the potential for massive blood loss.
In select cases, through conservative management, we are able to safely remove the placenta while sparing the uterus.
Leading the Way to Best Practices
We continue to advance the treatment of placenta accreta, increta and percreta. From groundbreaking research on minimizing blood loss during delivery, to participating in a national consortium of centers of excellence to establish best practices, we are dedicated to helping all women with MAP achieve the best possible outcome.